Report: Vaccine market to double by 2013

Pharma's bright spot: The vaccine market will more than double by 2013 due to a strong pipeline of new products and rising usage of current products around the world, a new research report says. Release

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.